Aug 26 (Reuters) - One day after a short seller claimed that
St. Jude Medical Inc's heart implants are vulnerable to
deadly cyber attacks, investors appear most concerned about
whether the accusation will derail St. Jude's $24 billion
planned deal for Abbott Labs to buy it.
Read more
No comments:
Post a Comment